Globally, RSV causes millions of respiratory infections each year and is responsible for a large proportion of ...

Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than ...

Stepping into 2026 is an exciting time for expecting parents a milestone marked by anticipation, joy, and hope. In this phase ...

Elanco's monoclonal antibody therapy, Trutect, received a conditional license from the federal agency in 2023.

Nirsevimab, a long-acting monoclonal antibody that confers passive immunity for infants up to 6 months old, was approved in ...

Allegro’s ACS37200 200-A Hall current sensor slashes power dissipation with its 50-µA shunt, offering 1,400 V of isolation in ...

Also earlier this year, Trump's EPA announced it would maintain existing designations for PFOS and PFOA as hazardous ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...

The government must exercise caution in its policy choices, ensuring that short-term growth ambition does not undermine ...

The defendants reject the charge, and the company maintains that there is no legal basis for the prosecution. The company ...

California is the first state to take an action against third-hand smoking. To know what it means, what its harmful effects ...